Merdury Biopharmaceutical Corporation (TPEX:6932)
5.49
+0.26 (4.97%)
Nov 10, 2026, 1:31 PM CST
| Market Cap | 2.35B -41.2% |
| Revenue (ttm) | n/a |
| Net Income | -51.62M |
| EPS | -0.12 |
| Shares Out | 427.65M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 317,823 |
| Open | 5.45 |
| Previous Close | 5.23 |
| Day's Range | 5.26 - 5.59 |
| 52-Week Range | 4.71 - 12.20 |
| Beta | -1.02 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |